Navid Mahmoodzadegan's most recent trade in Moelis & Co - Ordinary Shares - Class A was a trade of 57,008 2019 Incentive Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 57,008 | 0 | - | - | 2019 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 57,008 | 207,008 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 74.00 per share. | 19 Feb 2025 | 9,406 | 197,602 (0%) | 0% | 74 | 696,044 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 150,000 | 150,000 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 68,188 | 0 | - | - | 2021 Vested LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 30,421 | 30,421 | - | - | 2020 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 28,361 | 56,724 | - | - | 2021 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 23,030 | 230,966 | - | - | 2022 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 166,526 | 166,526 | - | - | 2023 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 3,151 | 70,837 | - | - | 2022 Performance LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 2,744 | 2,744 | - | - | 2023 LTI LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 447 | 57,008 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 486 | 56,561 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 618 | 56,075 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 54.92 per share. | 13 May 2024 | 44,980 | 0 (0%) | 0% | 54.9 | 2,470,302 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 579 | 55,456 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 54.11 per share. | 29 Feb 2024 | 50,772 | 64,463 (0%) | 0% | 54.1 | 2,747,273 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 53.88 per share. | 29 Feb 2024 | 19,483 | 44,980 (0%) | 0% | 53.9 | 1,049,744 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 253,996 | 253,996 | - | - | 2022 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 90,489 | 124,395 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 87,143 | 211,538 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 52.60 per share. | 21 Feb 2024 | 85,900 | 125,637 (0%) | 0% | 52.6 | 4,518,340 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 67,685 | 67,685 | - | - | 2022 Performance LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 56,723 | 85,085 | - | - | 2021 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 54,876 | 54,876 | - | - | 2019 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 35,612 | 0 | - | - | 2018 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 30,420 | 60,842 | - | - | 2020 LP Units of MCGEH | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 54.92 per share. | 21 Feb 2024 | 10,402 | 115,235 (0%) | 0% | 54.9 | 571,278 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.00 per share. | 21 Feb 2024 | 1 | 211,537 (0%) | 0% | 58 | 58 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Sale of securities on an exchange or to another person at price $ 55.29 per share. | 16 Feb 2024 | 25,642 | 54,217 (0%) | 0% | 55.3 | 1,417,746 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Sale of securities on an exchange or to another person at price $ 54.68 per share. | 16 Feb 2024 | 20,311 | 33,906 (0%) | 0% | 54.7 | 1,110,605 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Sale of securities on an exchange or to another person at price $ 55.82 per share. | 16 Feb 2024 | 20,001 | 79,859 (0%) | 0% | 55.8 | 1,116,456 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 1,151 | 109,752 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Mahmoodzadegan Navid | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 373 | 35,612 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2023 | 1,441 | 108,601 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2023 | 467 | 35,239 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 1,499 | 107,160 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 486 | 34,771 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 1,663 | 105,660 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 539 | 34,285 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Sale of securities on an exchange or to another person at price $ 43.05 per share. | 03 Mar 2023 | 23,323 | 99,860 (0%) | 0% | 43.0 | 1,004,055 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Sale of securities on an exchange or to another person at price $ 43.13 per share. | 28 Feb 2023 | 54,009 | 123,183 (0%) | 0% | 43.1 | 2,329,408 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Sale of securities on an exchange or to another person at price $ 43.22 per share. | 28 Feb 2023 | 52,209 | 177,192 (0%) | 0% | 43.2 | 2,256,473 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 141,808 | 141,808 | - | - | 2021 LP Units of Moelis & Company Group Employee Holdings LP | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 110,565 | 256,361 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Sale of securities on an exchange or to another person at price $ 42.06 per share. | 22 Feb 2023 | 68,561 | 229,401 (0%) | 0% | 42.1 | 2,883,676 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 68,188 | 68,188 | - | - | 2021 Vested LP Units of Moelis&Co Group Employee Holdings LP | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 60,841 | 91,262 | - | - | 2020 LP Units of Moelis & Company Group Employee Holdings LP | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 60,841 | 297,962 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 51,998 | 103,997 | - | - | 2019 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 33,745 | 33,745 | - | - | 2018 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 24,821 | 0 | - | - | 2017 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.06 per share. | 22 Feb 2023 | 19,240 | 237,121 (0%) | 0% | 42.1 | 809,263 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 2,089 | 155,995 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 903 | 67,490 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 332 | 24,821 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 2,047 | 153,906 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 886 | 66,586 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 325 | 24,489 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 2,001 | 151,858 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 865 | 65,700 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 318 | 24,163 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 1,895 | 149,857 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 820 | 64,834 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 301 | 23,845 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 152,103 | 152,103 | - | - | LP Units of Moelis & Company Group Employee Holdings LP | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 133,798 | 210,154 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Sale of securities on an exchange or to another person at price $ 47.12 per share. | 22 Feb 2022 | 53,518 | 145,796 (0%) | 0% | 47.1 | 2,521,768 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 49,320 | 147,962 | - | - | 2019 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 32,006 | 64,014 | - | - | 2018 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 28,928 | 0 | - | - | 2016 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 23,543 | 23,543 | - | - | 2017 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.12 per share. | 22 Feb 2022 | 10,840 | 199,314 (0%) | 0% | 47.1 | 510,797 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 8,689 | 197,282 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 4,229 | 96,020 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,074 | 47,086 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 1,274 | 28,928 | - | - | 2016 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 1,810 | 188,593 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 881 | 91,791 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 432 | 45,012 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 265 | 27,653 | - | - | 2016 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 8,591 | 186,782 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 4,181 | 90,910 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 2,050 | 44,580 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 1,259 | 27,388 | - | - | 2016 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 1,733 | 178,191 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 843 | 86,728 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 413 | 42,530 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 254 | 26,128 | - | - | 2016 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 151,446 | 151,446 (0%) | 0% | - | Class A Common Stock | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.29 per share. | 23 Feb 2021 | 75,090 | 76,356 (0%) | 0% | 54.3 | 4,076,653 | Class A Common Stock |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 44,114 | 176,457 | - | - | 2019 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 31,773 | 0 | - | - | 2015 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 28,627 | 85,884 | - | - | 2018 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 25,874 | 25,874 | - | - | 2016 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 21,056 | 42,116 | - | - | 2017 Incentive Restricted Stock Units | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 9,165 | 220,571 | - | - | 2019 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 4,758 | 114,512 | - | - | 2018 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 2,625 | 63,173 | - | - | 2017 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 2,150 | 51,748 | - | - | 2016 Incentive RSUs | |
| Moelis & Co - Ordinary Sha... | Navid Mahmoodzadegan | Director, Co-President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2020 | 1,320 | 31,773 | - | - | 2015 Incentive RSUs |